{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T16:13:55Z","timestamp":1770567235002,"version":"3.49.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#APP1175775"],"award-info":[{"award-number":["#APP1175775"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","award":["MS700568_0039"],"award-info":[{"award-number":["MS700568_0039"]}],"id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cladribine (2-chlorodeoxyadenosine, 2CdA) is one of the most effective disease-modifying drugs for multiple sclerosis (MS). Cladribine is a synthetic purine nucleoside analog that induces cell death of lymphocytes and oral cladribine treatment leads to a long-lasting disease stabilization, potentially attributable to immune reconstitution. In addition to its effects on lymphocytes, cladribine has been shown to have immunomodulatory effects on innate immune cells, including dendritic cells and monocytes, which could also contribute to its therapeutic efficacy. However, whether cladribine can modulate human macrophage\/microglial activation or monocyte differentiation is currently unknown. The aim of this study was to determine the immunomodulatory effects of cladribine upon monocytes, monocyte-derived macrophages (MDMs) and microglia. We analyzed the phenotype and differentiation of monocytes from MS patients receiving their first course of oral cladribine both before and three weeks after the start of treatment. Flow cytometric analysis of monocytes from MS patients undergoing cladribine treatment revealed that the number and composition of CD14\/CD16 monocyte subsets remained unchanged after treatment. Furthermore, after differentiation with M-CSF, such MDMs from treated MS patients showed no difference in gene expression of the inflammatory markers compared to baseline. We further investigated the direct effects of cladribine <jats:italic>in vitro<\/jats:italic> using human adult primary MDMs and microglia. GM-CSF-derived MDMs were more sensitive to cell death than M-CSF-derived MDMs. In addition, MDMs treated with cladribine showed increased expression of costimulatory molecules CD80 and CD40, as well as expression of anti-inflammatory, pro-trophic genes IL10 and MERTK, depending on the differentiation condition. Cladribine treatment <jats:italic>in vitro<\/jats:italic> did not modulate the expression of activation markers in human microglia. Our study shows that cladribine treatment <jats:italic>in vitro<\/jats:italic> affects the differentiation of monocytes into macrophages by modulating the expression of activation markers, which might occur similarly in tissue after their infiltration in the CNS during MS.<\/jats:p>","DOI":"10.3389\/fimmu.2022.678817","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T04:49:05Z","timestamp":1654490945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation"],"prefix":"10.3389","volume":"13","author":[{"given":"Tiago","family":"Medeiros-Furquim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Aprico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eze","family":"Nwoke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele D.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor J.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple Sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and Immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92826-2","article-title":"Cladribine (2-Chlorodeoxyadenosine)","volume":"340","author":"Beutler","year":"1992","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-317411","article-title":"Cladribine: Mechanisms and Mysteries in Multiple Sclerosis","volume":"89","author":"Jacobs","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70005-5","article-title":"Effect of Oral Cladribine on Time to Conversion to Clinically Definite Multiple Sclerosis in Patients With a First Demyelinating Event (ORACLE MS): A Phase 3 Randomised Trial","volume":"13","author":"Leist","year":"2014","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000360","article-title":"Both Cladribine and Alemtuzumab may Effect MS via B-Cell Depletion","volume":"4","author":"Baker","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1177\/1352458517727603","article-title":"Safety and Efficacy of Cladribine Tablets in Patients With Relapsing \u2013 Remitting Multiple Sclerosis: Results From the Randomized Extension Trial of the CLARITY Study","volume":"24","author":"Giovannoni","year":"2018","journal-title":"Mult Scler J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12109","article-title":"2-Chlorodeoxyadenosine (Cladribine) Induces Apoptosis in Human Monocyte-Derived Dendritic Cells","volume":"173","author":"Singh","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.11.027","article-title":"Cladribine Exerts an Immunomodulatory Effect on Human and Murine Dendritic Cells","volume":"18","author":"Kraus","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2011.09.010","article-title":"Cladribine Inhibits Cytokine Secretion by T Cells Independently of Deoxycytidine Kinase Activity","author":"Laugel","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0129182","DOI":"10.1371\/journal.pone.0129182","article-title":"Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells","volume":"10","author":"Korsen","year":"2015","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02433.x","article-title":"Cladribine Impedes In Vitro Migration of Mononuclear Cells: A Possible Implication for Treating Multiple Sclerosis","volume":"16","author":"Kopadze","year":"2009","journal-title":"Eur J Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199732020-00003","article-title":"The Clinical Pharmacokinetics of Cladribine","volume":"32","author":"Liliemark","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"B14","article-title":"Pharmacokinetics of Cladribine (2-Chlorodeoxyadenosine) in Children With Acute Leukemia","volume":"54","author":"Kearns","year":"1994","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0695-9","article-title":"The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis","volume":"58","author":"Hermann","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103264","article-title":"Acting Centrally or Peripherally: A Renewed Interest in the Central Nervous System Penetration of Disease-Modifying Drugs in Multiple Sclerosis","volume":"56","author":"Correale","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7188","article-title":"Multiple Sclerosis Genomic Map Implicates Peripheral Immune Cells and Microglia in Susceptibility","volume":"365","author":"Genomics","year":"2019","journal-title":"Science (80)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and Temporal Heterogeneity of Mouse and Human Microglia at Single-Cell Resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08976-7","article-title":"Transcriptional Profiling of Human Microglia Reveals Grey\u2013White Matter Heterogeneity and Multiple Sclerosis-Associated Changes","volume":"10","author":"van der Poel","year":"2019","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pneurobio.2015.05.003","article-title":"Alternatively Activated Microglia and Macrophages in the Central Nervous System","volume":"131","author":"Franco","year":"2015","journal-title":"Prog Neurobiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.37","article-title":"Mechanisms of Neurodegeneration and Axonal Dysfunction in Multiple Sclerosis","volume":"10","author":"Friese","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029","article-title":"Neurotoxic Reactive Astrocytes are Induced by Activated Microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20132477","article-title":"Differential Roles of Microglia and Monocytes in the Inflamed Central Nervous System","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1084\/jem.192.6.899","article-title":"CC Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis","volume":"192","author":"Fife","year":"2000","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1075","article-title":"Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)","volume":"192","author":"Izikson","year":"2000","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp144","article-title":"CCR2+Ly-6chi Monocytes are Crucial for the Effector Phase of Autoimmunity in the Central Nervous System","volume":"132","author":"Mildner","year":"2009","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2887","article-title":"Infiltrating Monocytes Trigger EAE Progression, But do Not Contribute to the Resident Microglia Pool","volume":"14","author":"Ajami","year":"2011","journal-title":"Nat Neurosci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00023","article-title":"Toward a Refined Definition of Monocyte Subsets","volume":"4","author":"Ziegler-Heitbrock","year":"2013","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00477-1","article-title":"Non-Classical Monocytes are Biased Progenitors of Wound Healing Macrophages During Soft Tissue Injury","volume":"7","author":"Olingy","year":"2017","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01726","article-title":"Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection","volume":"9","author":"Sampath","year":"2018","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501960","article-title":"Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System","volume":"196","author":"Waschbisch","year":"2016","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.1025","article-title":"Subsets of Activated Monocytes and Markers of Inflammation in Incipient and Progressed Multiple Sclerosis","volume":"96","author":"Gjelstrup","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12004","article-title":"Nonclassical Monocytes: Are They the Next Therapeutic Targets in Multiple Sclerosis","volume":"96","author":"Ajami","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107270","article-title":"Cladribine Inhibits Secretion of Pro-Inflammatory Cytokines and Phagocytosis in Human Monocyte-Derived M1 Macrophages","volume":"91","author":"Mathiesen","year":"2021","journal-title":"In Vitro. Int Immunopharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating Neurologic Impairment in Multiple Sclerosis: An Expanded Disability Status Scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuron.2017.04.043","article-title":"Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures","volume":"94","author":"Bohlen","year":"2017","journal-title":"Neuron"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot073973","article-title":"Purification of Oligodendrocyte Lineage Cells From Mouse Cortices by Immunopanning","volume":"2013","author":"Emery","year":"2013","journal-title":"Cold Spring Harb Protoc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An Open-Source Platform for Biological-Image Analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2013\u0394\u0394ct Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2018.12.002","article-title":"The Ultimate qPCR Experiment: Producing Publication Quality, Reproducible Data the First Time","volume":"37","author":"Taylor","year":"2019","journal-title":"Trends Biotechnol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103426","article-title":"Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models","volume":"188","author":"Lacey","year":"2012","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13473","article-title":"Cladribine Modifies Functional Properties of Microglia","volume":"201","author":"J\u00f8rgensen","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nri3871","article-title":"Immunopathology of Multiple Sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"528","DOI":"10.26226\/morressier.59a3edabd462b8028d895161","article-title":"Innate Immune Cell Counts in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) Treated With Cladribine Tablets 3.5 Mg\/Kg in CLARITY and CLARITY Extension","volume":"25","author":"Soelberg-Sorensen","year":"2018","journal-title":"Eur J  Neurol"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419854986","article-title":"Effects of Cladribine Tablets on Lymphocyte Subsets in Patients With Multiple Sclerosis: An Extended Analysis of Surface Markers","volume":"12","author":"Stuve","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51206","article-title":"Long-Term Peripheral Immune Cell Profiling Reveals Further Targets of Oral Cladribine in MS","volume":"7","author":"Moser","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity Against Tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.stem.2020.01.017","article-title":"C\/Ebp\u03b2-Dependent Epigenetic Memory Induces Trained Immunity in Hematopoietic Stem Cells","volume":"26","author":"de Laval","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining Trained Immunity and Its Role in Health and Disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic Programming of Monocyte-to-Macrophage Differentiation and Trained Innate Immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science (80 )"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24497","article-title":"Clinical and Pathological Insights Into the Dynamic Nature of the White Matter Multiple Sclerosis Plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann Neurol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2144\/000114435","article-title":"A Phased Strategy to Differentiate Human CD14+monocytes Into Classically and Alternatively Activated Macrophages and Dendritic Cells","volume":"61","author":"Zarif","year":"2016","journal-title":"Biotechniques"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0012OC","article-title":"Phenotypic,functional,and Plasticity Features of Classical and Alternatively Activated Human Macrophages","volume":"53","author":"Tarique","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2012.03.026","article-title":"The CSF-1 Receptor Ligands IL-34 and CSF-1 Exhibit Distinct Developmental Brain Expression Patterns and Regulate Neural Progenitor Cell Maintenance and Maturation","volume":"367","author":"Nandi","year":"2012","journal-title":"Dev Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2360","article-title":"IL-34 Is a Tissue-Restricted Ligand of CSF1R Required for the Development of Langerhans Cells and Microglia","volume":"13","author":"Wang","year":"2012","journal-title":"Nat Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.01.007","article-title":"Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System","volume":"46","author":"Spath","year":"2017","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.010","article-title":"The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity","volume":"43","author":"Croxford","year":"2015","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201643668","article-title":"LncRNA GAS5 Inhibits Microglial M2 Polarization and Exacerbates Demyelination","volume":"18","author":"Sun","year":"2017","journal-title":"EMBO Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141656","article-title":"Inefficient Clearance of Myelin Debris by Microglia Impairs Remyelinating Processes","volume":"212","author":"Lampron","year":"2015","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3531","article-title":"A New Type of Microglia Gene Targeting Shows TAK1 to be Pivotal in CNS Autoimmune Inflammation","volume":"16","author":"Goldmann","year":"2013","journal-title":"Nat Neurosci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00523","article-title":"CSF1R Stimulation Promotes Increased Neuroprotection by CD11c+ Microglia in EAE","volume":"12","author":"Wlodarczyk","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502562","article-title":"MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells","volume":"196","author":"Healy","year":"2016","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2015.18","article-title":"Mer Receptor Tyrosine Kinase Mediates Both Tethering and Phagocytosis of Apoptotic Cells","volume":"6","author":"Dransfield","year":"2015","journal-title":"Cell Death Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200662","article-title":"Efficient Clearance of Early Apoptotic Cells by Human Macrophages Requires M2c Polarization and MerTK Induction","volume":"189","author":"Zizzo","year":"2012","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-012-9387-7","article-title":"Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia","volume":"7","author":"Singh","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/J.INTIMP.2022.108571","article-title":"2-Chlorodeoxyadenosine (Cladribine) Preferentially Inhibits the Biological Activity of Microglial Cells","volume":"105","author":"Aybar","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneuroim.2013.08.009","article-title":"Cladribine Interferes With IL-1\u03b2 Synaptic Effects in Experimental Multiple Sclerosis","volume":"264","author":"Musella","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B70","article-title":"Clinical Trial: Effect of Cladribine Treatment on Microglial Activation in the CNS (CLADPET)","author":"Airas","year":"2020"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of Microglia in the Central Nervous System Diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol Neurobiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.678817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T04:49:12Z","timestamp":1654490952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.678817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2022.678817"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.678817","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"article-number":"678817"}}